ELND 002
/ Perrigo Company
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 06, 2010
A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
-
Elan; P1, N=100;
1 to 1
Of
1
Go to page
1